Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)
Others
Ratios

Avidity Biosciences (RNA) Profit After Tax: 2018-2024

Historic Profit After Tax for Avidity Biosciences (RNA) over the last 7 years, with Dec 2024 value amounting to -$322.3 million.

  • Avidity Biosciences' Profit After Tax fell 116.97% to -$174.4 million in Q3 2025 from the same period last year, while for Sep 2025 it was -$549.8 million, marking a year-over-year decrease of 96.01%. This contributed to the annual value of -$322.3 million for FY2024, which is 51.87% down from last year.
  • Latest data reveals that Avidity Biosciences reported Profit After Tax of -$322.3 million as of FY2024, which was down 51.87% from -$212.2 million recorded in FY2023.
  • Over the past 5 years, Avidity Biosciences' Profit After Tax peaked at -$44.4 million during FY2020, and registered a low of -$322.3 million during FY2024.
  • Moreover, its 3-year median value for Profit After Tax was -$212.2 million (2023), whereas its average is -$236.2 million.
  • Data for Avidity Biosciences' Profit After Tax shows a maximum YoY crashed of 166.06% (in 2021) over the last 5 years.
  • Over the past 5 years, Avidity Biosciences' Profit After Tax (Yearly) stood at -$44.4 million in 2020, then crashed by 166.06% to -$118.0 million in 2021, then slumped by 47.44% to -$174.0 million in 2022, then fell by 21.97% to -$212.2 million in 2023, then plummeted by 51.87% to -$322.3 million in 2024.